Vitruvias Therapeutics recalls
Vitruvias Therapeutics appears in 1 official U.S. recall notice indexed by RecallRadar, most recently on 2026-09-23.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 1 |
|---|---|
| Published | 2026-09-23 |
| By agency | FDA Drug (1) |
| By classification | Class I (1) |
| By status | ongoing (1) |
| Distribution named in notices | US |
Recalls
- Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only,…
FDA Drug · Class I · 2026-09-23 · Vitruvias Therapeutics
Reason: Superpotent Drug